Hero Background Image
Quarterly Letter

Baron Asset Fund | Q3 2026

Andrew Peck, SVP, Co-CIO and Portfolio Manager

Dear Baron Asset Fund Shareholder,

During the quarter, markets contended with the first Federal Reserve rate hike since 2023, stubborn inflation, higher oil prices, and ongoing geopolitical tensions. Against this backdrop, U.S. equities delivered mixed results. July saw investors rotate away from high-momentum AI and technology stocks followed by a two-month period when these same stocks recovered. Market leadership narrowed sharply toward large-cap technology and AI-linked names, driving large-cap growth indexes to end the period slightly higher while small-cap and mid-cap growth indexes ended lower.

Baron Asset Fund (the Fund) declined 6.22% (Institutional Shares) in the third quarter, performing similarly to the Russell Midcap Growth Index (the Index), which fell 5.84%. The quarter marked a sharp reversal of the market conditions that predominated during the first half of the year. The so-called “AI winners” cohort that had powered the Index higher in recent quarters, including semiconductor, data center, and power companies, sold off. Software and other higher-quality, lower-beta businesses led amid heightened market volatility.

Annualized performance (%) for periods ended September 30, 2026†
 Fund Retail
Shares1,2
Fund Institutional
Shares1,2,3
Russell Midcap
Growth Index1
Russell 3000
Index1
QTD5(6.28) (6.22) (5.84) 1.40 
YTD52.66  2.86  1.01  12.42 
1 Year10.69  10.97  (2.73) 15.13 
3 Years11.22  11.50  15.36  22.26 
5 Years2.15  2.41  4.92  12.64 
10 Years10.78  11.06  11.86  14.73 
15 Years12.26  12.56  13.17  15.27 
Since Inception
(6/12/1987)
11.00  11.12  10.274 10.76 

 

Performance listed in the above table is net of annual operating expenses. Annual expense ratio for the Retail Shares and Institutional Shares as of January 28, 2026 was 1.31% and 1.05%, respectively. The performance data quoted represents past performance. Past performance is no guarantee of future results. The investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost. The Funds' transfer agency expenses may be reduced by expense offsets from an unaffiliated transfer agent, without which performance would have been lower. Current performance may be lower or higher than the performance data quoted. For performance information current to the most recent month end, visit BaronCapitalGroup.com or call 1-800-99-BARON.

According to MSCI’s Barra factor attribution, style factors were a substantial tailwind to the Fund’s performance for the first time in several quarters. The Fund’s persistent underexposure to Momentum and Beta paid off as both factors reversed, and its larger-cap positioning within the mid-cap universe added further value. Many of the Fund’s software and services holdings also performed well, helping partly offset stock-specific weakness associated with the Fund's large position in rocket, satellite, and spacecraft manufacturer Space Exploration Technologies Corp. (SpaceX).

From a sector perspective, Industrials contributed approximately 170 basis points of relative gains, driven by strong stock selection and lower exposure to this lagging sector. Notable declines in aerospace & defense and construction & engineering stocks pressured the Index’s Industrials. The Fund’s Industrials holdings held up better, thanks largely to double-digit gains from financial software and services provider SS&C Technologies Holdings, Inc. and defense and government consulting firm Booz Allen Hamilton Holding Corporation. Both companies delivered solid fundamental results and benefited from the broader rebound in software, information services, and consulting stocks as concerns about AI disruption eased.

Solid stock selection in Health Care and Real Estate also added value, led by life science tools manufacturer Mettler-Toledo International Inc. and senior housing REIT Welltower Inc. As discussed below, Mettler-Toledo’s stock performed well as a result of strong second quarter results and a raised full-year outlook. Welltower posted modest gains during the quarter despite a challenging backdrop in which most real estate securities declined, extending its strong performance from the first half of the year. The company continued to execute well, delivering robust cash flow growth driven by strong occupancy gains, healthy rent growth, and ongoing margin expansion, all of which reflect powerful demographic tailwinds supporting demand for senior housing.

The Fund also benefited from being overexposed to Financials, one of the better performing sectors in the Index, as well as its lack of or lower exposure to the lagging Consumer Discretionary and Utilities sectors. Together, these contributed nearly 150 basis points of relative gains. In addition, several of the Fund’s holdings that had sold off meaningfully earlier in the year based on fears of AI-driven business model disruption staged partial recoveries. These included syndicated research provider Gartner, Inc., application software vendors Guidewire Software, Inc. and Veeva Systems Inc., and financial data and analytics firm FactSet Research Systems Inc.

Partly offsetting these gains was the Fund’s overexposure to the lagging Communication Services sector through its sizable position in SpaceX, which detracted approximately 160 basis points from relative performance. As discussed below, we remain confident in SpaceX’s long-term prospects. Underexposure to Information Technology (IT) and Energy, two of the best performing sectors in the Index, also proved costly, detracting more than 170 basis points from relative results.

In last quarter’s letter, we discussed how multiple contraction across the software and services group was the main driver of recent underperformance, overshadowing improving business fundamentals. That shifted in the September quarter, as the Fund’s software and services stocks rebounded after a period of disappointing performance. The group, which includes Veeva, Gartner, Procore Technologies, Inc., SS&C, FactSet, Samsara Inc., and Guidewire, appreciated by double digits and contributed more than 200 basis points, driven by a combination of accelerating growth and multiple expansion.

The Fund nonetheless declined for the quarter because of weakness in the Other group. SpaceX’s pullback, along with multiple contraction among many of the Fund’s AI infrastructure and power beneficiaries, including Forgent Power Solutions, Inc., Vertiv Holdings Co, Cerebras Systems Inc., Quanta Services, Inc., and Amphenol Corporation, weighed on performance. Encouragingly, these losses stemmed from multiple compression rather than fundamental issues.
 

Returns: Fund -6.22% vs. Russell Midcap Growth Index -5.84%

1 Change in valuation multiple and growth rate for the Other holdings group exclude SpaceX, given its outsized percentages. Including SpaceX, the group’s change in valuation multiple was -35% and its growth rate was +74%.

Growth is based on the fundamental item used to value each company; it is not a uniform revenue or earnings metric. Group returns, valuation changes and growth are weighted calculations; they are not an additive return bridge. Some quarterly purchases and sales are excluded. The residual is unassigned; cash, fees, and omitted holdings may contribute.

Sources: Baron Capital, FactSet Estimates, and FactSet PA.

Top Contributors & Detractors

Top contributors to performance for the quarter
 Year
Acquired
Contribution to Return
(%)
Gartner, Inc.20070.84 
Mettler-Toledo International Inc.20080.62 
Guidewire Software, Inc.20130.46 
Veeva Systems Inc.20170.42 
Repligen Corporation20250.35 

We believe that shares of syndicated research provider Gartner, Inc. rallied as investors began to appreciate the valuation disconnect in beaten down information services stocks. We believe that the growth rate of Gartner’s contract value is poised to reaccelerate as the company enhances its product offerings, retrains its sales force, and benefits from easier comparisons in its public sector end market. We also view Gartner as an underappreciated beneficiary of AI, as organizations increasingly seek guidance from trusted third-parties in navigating the risks and opportunities presented by AI technologies. In addition, we expect the company’s earnings and free cash flow to grow meaningfully faster than its revenue as Gartner expands margins and returns excess capital through share repurchases. Management is on pace to deploy nearly $2 billion of free cash flow toward share repurchases this year, which we estimate could reduce the company's share count by roughly 15% to 20%.

Mettler-Toledo International Inc. is a leading provider of precision instruments and services used in research and development, quality control, and manufacturing processes across the life sciences, food, and chemicals industries. The stock contributed to performance following strong second-quarter results and a raised full-year outlook. Local-currency sales grew 6%, exceeding prior guidance of 3%, supported by better-than-expected growth in China and strength across other emerging markets. Earnings per share also exceeded sell-side estimates. In addition, positive commentary on business trends from life sciences tools peers, including Thermo Fisher Scientific and Agilent, contributed to Mettler-Toledo’s share price appreciation. We think the company is well positioned to benefit from several positive trends, including life sciences investment in China and new U.S. plant construction by biopharmaceutical companies. Over the long term, we believe Mettler-Toledo should generate mid-teens or better annual earnings-per-share (EPS) growth.

Shares of property and casualty insurance software vendor Guidewire Software, Inc. rallied as investors began to appreciate the valuation disconnect in beaten down software stocks. Guidewire’s InsuranceSuite platform serves as the core system of record for insurance carriers, functioning as the single source of truth for policies, claims, premiums, and payments. Given the complexity, highly regulated nature, and digital format of insurance policies, we believe this system is particularly critical and valuable. We think the core-system opportunity alone represents nearly $20 billion of annual recurring revenue (ARR). In our view, AI will meaningfully expand this opportunity by enabling automation and intelligence on top of the company’s existing platform. Guidewire is already bringing new AI-enabled capabilities to market and signing customers, and we expect adoption to accelerate over the coming year. Finally, we expect Guidewire to benefit from AI-driven productivity gains, which should help the company grow faster while reducing its operating costs.

Top detractors from performance for the quarter
 Year
Acquired
Contribution to Return
(%)
Space Exploration Technologies Corp.2020(4.01) 
Vertiv Holdings Co2025(0.63) 
Hyatt Hotels Corporation2009(0.45) 
Fair Isaac Corporation2020(0.44) 
Quanta Services, Inc.2023(0.42) 

Space Exploration Technologies Corp. develops and launches advanced rockets, satellites, and spacecraft, with the long-term goal of making humanity multi-planetary. The stock detracted from performance as shares pulled back from highs reached after its initial public offering, despite strong underlying business fundamentals. We remain long-term shareholders and believe the company is in the early stages of a multi-decade growth opportunity. SpaceX’s first results as a public company reinforced our conviction, with revenue nearly doubling year-over-year and losses narrowing sharply on high incremental margins. Growth was driven by rapidly scaling, multibillion-dollar compute-hosting deals with AI leaders, including Anthropic and Google, alongside momentum in its Starlink Internet connectivity business. Management guided to a robust $100 billion annualized revenue run rate by year-end 2026 and up to five times more compute exiting 2027, well above Street expectations. SpaceX also closed its acquisition of Cursor, a premier enterprise AI-powered coding platform, accelerated product development with Grok Bot and more advanced Grok models, and progressed toward full reusability of its Starship rocket.

Vertiv Holdings Co is a global leader in critical digital infrastructure for data centers, including electrical and thermal management equipment and related services. Shares declined as second quarter organic growth came in slightly below guidance, even as management raised its full-year outlook, with broader weakness in AI infrastructure stocks adding pressure. Vertiv is benefiting from the industry’s shift toward modular solutions to alleviate field labor shortages, thanks to its broad product portfolio and large field service team. The company is also well positioned to support upcoming technology transitions, including liquid cooling and direct current architectures. We see meaningful long-term upside from strong organic growth, margin expansion, and complementary acquisitions, supported by a strong balance sheet.

Global hotelier Hyatt Hotels Corporation detracted from performance as investors grew concerned that higher oil prices, interest rates, and inflation could pressure consumers and travel budgets. Nevertheless, consumer spending remains resilient, particularly on travel and experiences. Hyatt continues to grow new units at a mid-single-digit rate, while revenue per available room is accelerating from low- to mid-single-digit growth. We expect these trends to support margin and cash flow expansion, generating capital to reinvest in the business, pursue accretive tuck-in acquisitions, and increase share repurchases. Hyatt’s strong balance sheet provides additional flexibility to fund growth or to allocate more capital to share buybacks. The stock continues to trade at a significant discount to its public hotel peers despite a similar mix of attractive fee-for-service business. We believe this discount should narrow as investors see continued growth in the business.

Portfolio Structure

As of September 30, 2026, the Fund held 50 positions. The Fund’s 10 largest holdings represented 62.0% of net assets, and the 20 largest represented 76.7%. The Fund’s largest weighting was in the Communication Services sector at 31.7% of net assets. This sector includes our investment in SpaceX. The Fund held 16.6% of its net assets in the IT sector, which includes application software companies, electronic components businesses, and IT consulting firms. The Fund held 14.5% of its net assets in the Industrials sector, which includes investments in research & consulting companies, construction and engineering firms, electrical components & equipment businesses, and aerospace & defense contractors. The Fund held 11.8% of its net assets in Health Care, which includes investments in life sciences tools & services companies and health care equipment businesses. The Fund also had significant weightings in Financials at 10.7% and Consumer Discretionary at 6.1%.

As the table above shows, the Fund’s largest investments have mostly been owned for significant periods, with 7 of the 10 largest holdings held for longer than a decade. This is consistent with our approach of investing for the long term in companies benefiting from secular growth trends with significant competitive advantages and best-in-class management teams.

Top 10 holdings
 Year AcquiredMarket Cap
When Acquired
($B)
Quarter End
Market Cap
($B)
Quarter End
Investment Value
($M)
Percent of
Net Assets
(%)
Space Exploration Technologies Corp.202047.0 2,047.6 1,077.4 30.5 
Amphenol Corporation201926.2 207.9 173.4 4.9 
Mettler-Toledo International Inc.20082.4 30.3 135.5 3.8 
Arch Capital Group Ltd.20030.9 31.5 133.8 3.8 
IDEXX Laboratories, Inc.20062.5 41.1 130.1 3.7 
Quanta Services, Inc.202321.8 96.6 126.3 3.6 
Guidewire Software, Inc.20132.8 11.7 120.5 3.4 
Verisk Analytics, Inc.20094.0 21.8 112.9 3.2 
Gartner, Inc.20072.9 11.8 98.1 2.8 
The Charles Schwab Corporation19921.0 169.0 84.9 2.4 

Recent Activity

Top net purchases for the quarter
 Quarter End Market Cap
($B)
Net Amount Purchased
($M)
Rubrik, Inc.24.3 18.5 
Edwards Lifesciences Corporation49.8 17.3 
Charles River Laboratories International, Inc.14.1 14.1 
Airbnb, Inc.96.2 2.2 
Samsara Inc.22.3 1.2 

We initiated a position in Rubrik, Inc., which provides cyber resilience software that backs up an organization's data and user identities and restores them quickly and cleanly after a ransomware attack or breach. The company's founding insight was that legacy backup products, built decades ago to recover from equipment failures and natural disasters, were poorly suited to an era in which attackers deliberately destroy or encrypt backup copies before demanding a ransom. Rubrik instead designed its platform on the assumption that breaches are inevitable. Its backup copies cannot be altered or deleted, and the platform continuously analyzes its history of changes to identify threats and the last uncompromised point to which a customer can safely return.

Rubrik’s approach has enabled the company to steadily gain market share from incumbent software vendors. It now includes more than 40% of the Fortune 500 as customers and generates approximately $1.7 billion of subscription ARR, which is growing more than 30% a year.

We believe the spread of AI makes Rubrik's platform more essential. Increasingly capable AI models are making cyberattacks cheaper, faster, and more sophisticated, compressing the time between intrusion and damage from months to minutes and elevating recovery to a board-level priority. AI is also multiplying the data that companies must protect and introducing a new class of risk. Autonomous AI agents can modify or delete corporate data at machine speed.

Rubrik's Agent Cloud product monitors these agents and can surgically reverse their harmful actions, and it has already won its first paying customers. The company has a strong record of turning new products into meaningful businesses, most recently identity recovery, which surpassed $50 million of ARR roughly a year after launch. More than half of ARR now comes from products beyond its original on-premise backup offering. With penetration still in the low teens among large enterprises and existing customers increasing their spending by roughly 20% a year, we see a long runway for growth. As the business scales, we estimate free cash flow margins to expand toward management's long-term target of 25% or more, which should bode well for the stock long term.

Charles River Laboratories International, Inc. is a leading provider of outsourced “pre-clinical” drug development services: the research models, toxicology studies, and quality-control testing that a therapeutic drug requires on its path toward human trials. About 60% of the company’s revenue comes from its Discovery and Safety Assessment (DSA) segment, which runs the GLP toxicology studies that regulators demand before a drug can enter clinical trials. Charles River holds roughly one-third of the outsourced in vivo safety assessment market, supports around 1,500 Investigational New Drug programs a year, and has worked on more than 80% of recent FDA-approved drugs.

Another roughly 20% of revenues are in its Research Models and Services segment, which breeds the mice and animals used in early-stage research. The remaining 20% or so is Manufacturing Solutions: endotoxin and microbial testing, as well as biologics lot-release testing. Both are written into validated manufacturing processes and regulatory filings, making it difficult for clients to switch vendors.

Charles River suffered nearly three years of organic revenue decline as biotechnology funding dried up, and this cycle is now turning. In its most recent quarter, Charles River posted its first organic growth since late 2023. The net book-to-bill ratio in its key DSA segment reached 1.19 times, the highest level in nearly four years. The pharmaceutical industry has long under-invested in its early-stage drug development pipeline, and Charles River is benefitting as that pipeline is replenished. Management has also simplified Charles River’s portfolio, divesting assets to focus on its core business.

Management recently committed to a meaningful acceleration in Charles River’s organic revenue growth of 5% to 7% through 2030, ongoing operating margin expansion, and low double-digit compounded EPS growth. We view these goals as achievable, and perhaps conservative. Management itself described their targets as having "no moonshots," and they exclude any benefit from AI.

We believe that AI is more likely to prove a tailwind than a threat to Charles River’s business. AI is emerging as a potentially transformative technology assisting in identifying potential candidates in the drug discovery process. We expect Charles River to remain integral to validating that expanding pipeline of potential new drugs. In June, Charles River became the partner for TuneLab, a platform Eli Lilly built to allow other drug developers to use its AI models. Charles River's role is to run standardized animal safety testing for participating companies, generating the kind of clean, consistent data these models need to learn from. We believe that the largest constraint on drug research successfully integrating AI is data, not algorithms. We expect researchers to conduct additional experiments to supplement their own data, and this increased activity should be a multi-year tailwind of demand for Charles River’s services.

We continued to build our position in Edwards Lifesciences Corporation, a leading manufacturer of heart valve replacement and repair products. We discussed the company in detail last quarter.

Top net sales for the quarter
 Quarter End Market Cap or Market Cap When Sold
($B)
Net Amount Sold
($M)
Space Exploration Technologies Corp.2,047.6 128.9 
Amphenol Corporation207.9 48.5 
Quanta Services, Inc.96.6 36.1 
The Cooper Companies, Inc.10.5 22.5 
DraftKings Inc.10.5 18.5 

We reduced our position in Space Exploration Technologies Corp., which remains an outsized holding in the Fund. As discussed last quarter, we remain quite optimistic about the company’s future prospects in multiple very large and growing markets, including rocket launches, voice and internet connectivity through its Starlink satellite network, AI models, and space-based AI infrastructure. The Fund’s shares in SpaceX are subject to a staggered lockup that extends through August 2027, and we intend to continue reducing our holdings over time. We also reduced our holdings in two stocks that have performed well in 2026, both beneficiaries of the massive ongoing investment into AI data centers—Amphenol Corporation, which makes various interconnect, sensor and antenna solutions, and Quanta Services, Inc., a specialty contractor focused on electrical generation and infrastructure. We exited positions in two companies that failed to meet our growth expectations—contact lens manufacturer The Cooper Companies, Inc. and online sports betting firm DraftKings Inc.

Outlook

As discussed last quarter, recent Index returns have been disproportionately driven by a narrow group of stocks deemed to be long-term winners in an AI-driven transformation of the global economy. Many investors have been chasing stock momentum and intriguing stories without paying sufficient attention to these businesses’ extended valuations and possible long-term competitive risks.

In contrast, we believe that many of the Fund’s holdings—in areas including software, IT consulting, business services, real estate brokerage, insurance brokerage, and wealth management—have been improperly penalized. We believe that investors’ concerns are overstated about looming AI-driven disruption to these companies’ business models and profitability. We believe this sell-off has indiscriminately punished many high-quality, competitively advantaged businesses.

We are encouraged that several of these stocks performed better this quarter. Nevertheless, many still trade at or near historically low valuation levels, even though their ongoing financial results demonstrate these businesses’ resilience. We remain optimistic that these strong results—and stock price appreciation—will continue. We believe the market will continue to recognize that these companies are utilizing AI in ways that should continually improve their products, lower their cost structures and enhance, rather than undermine, their competitive positions.

Our Space Exploration Technologies Corp. investment exposes the Fund to the long-term growth of AI, as well as several other large, dynamic markets. The Fund expects to remain a significant investor in SpaceX. But, as the lockup on its holdings expires, the Fund will manage its position size. We will balance our enthusiasm for SpaceX’s business prospects against the Fund’s objective to remain appropriately diversified among securities and industry sectors, as well as its mid-cap growth investment mandate.

We remain frustrated by the absolute and relative performance of mid-cap growth stocks. The Russell Midcap Growth Index has dramatically underperformed the Russell 1000 Growth Index, the primary large-cap growth index, during the past decade, and the divergence between these indexes continues to become more pronounced. Over the past five years, for example, mid-cap growth has trailed large-cap growth by nearly 900 basis points annualized.

Based on rolling five-year returns for the two indexes, mid-cap growth’s relative underperformance is currently at approximately the 99th percentile of historical results. We believe this period of nearly unprecedented underperformance is unlikely to persist, which makes this an attractive time to invest in fast-growing, competitively advantaged, well-managed mid-cap businesses.

Thank you for investing alongside me.

Sincerely,

Portfolio Manager Andrew Peck signature
Andrew PeckPortfolio Manager

Featured Fund

Learn more about Baron Asset Fund.